At the Medicines and Healthcare products Regulatory Agency our research programme plays a leading role in protecting and improving public health and supporting innovation.

At the South Mimms laboratories of the Science, Research and Innovation group we develop biological standards and reference materials, test biological medicinal products and carry out underpinning scientific research; activities that are essential for making sure the biological medicines patients receive are safe and effective.

Our collaborative, multi-institutional 3-year PhD studentships offer an opportunity for you to develop knowledge and expertise in biological medicines and gain valuable experience working across the MHRA and the partner University. 

Applications for the 2023 programme are now open.

Find out more on the available studentships below:

PhD Vaccines team

Mucosal delivery of universal protein subunit and mRNA vaccines against Group B streptococci

Application deadline: 31 January 2023


Investigating the immune-stimulating effects and therapeutic potential of conjugates for antibody-mediated delivery of nucleic acid adjuvants to the tumour microenvironment

Application deadline: 31 January 2023

PhD_Advanced therapies

Understanding the consequences of redox modification of monoclonal antibody therapies: Improving current treatments and developing next-generation therapies

Application deadline: 31 January 2023

If you have any questions about our PhD studentship programme, contact us at 

About the South Mimms laboratories

Our scientists work at the interface of industry, academia and medicines regulation, collaborating with manufacturers, regulators and control laboratories and researchers worldwide to support the use and development of biological medicines. Because of their specialist expertise, our scientists are often required to respond rapidly to public health emergencies, such as pandemic influenza, or safety issues associated with the use of biologics. 

We also help to develop national and international policies related to the use of biological medicines, sharing our knowledge and expert advice with key committees and policy making bodies.  

To allow us to protect and improve public health we receive some core funding from the UK Department of Health and Social Care, and also supply reference materials and undertake control testing. Our scientific research is supported by external research grant funding secured from a range of international as well as national grant awarding bodies.